Back to search

Article

Molecular landscape and risk stratification in acute myeloid leukemia - insights from the real-world REFORM-AML cohort

2026-08-31

Abstract excerpt

Large genomically annotated acute myeloid leukaemia (AML) datasets exist, but population-based contemporary cohorts remain scarce. Here we report clinicopathological, genomic, and outcome data from Danish AML patients. 2,512 AML patients were identified between 2015-2022, of whom 33.8% had available NGS data (NGS+). In patients ≤70 years, baseline characteristics and outcomes were comparable between NGS+ and NGS-...

Identifiers and source

Literature Corpus work
72378744-9f2b-5092-b5e0-99821baa1111
DOI
10.64898/2026.08.27.26361552
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular landscape and risk stratification in acute myeloid leukemia - insights from the real-world REFORM-AML cohortDOI 10.64898/2026.08.27.26361552
Genomic and clinical determinants of outcome in Irish AML: a real-world analysis (2007-2025), single centre experience.Semantic proximity
Unified classification and risk-stratification in Acute Myeloid LeukemiaSemantic proximity
Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.Semantic proximity
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.Semantic proximity
Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China.Semantic proximity
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.Semantic proximity
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.Semantic proximity
Genomic Classification and Prognosis in Acute Myeloid Leukemia.Semantic proximity
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.Semantic proximity
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.Semantic proximity
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Semantic proximity
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.Semantic proximity
Select a neighboring publication to make it the new centre.